Welcome to our dedicated page for Acadia Healthcar SEC filings (Ticker: ACHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a behavioral healthcare company whose subsidiaries own and operate inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. These regulatory documents offer detailed information about Acadia’s operations, financial performance, governance and material events.
Acadia’s periodic reports and current reports on Form 8-K disclose items such as quarterly and annual financial results, guidance updates, executive appointments and departures, capital expenditure plans and bed growth expectations. For example, 8-K filings have reported the company’s quarterly results, preliminary guidance for future capital expenditures and bed additions, and changes in senior leadership roles, including the appointment of a new Chief Financial Officer and the resignation of the Chief Operating Officer.
Other 8-K filings describe material legal and financial developments, such as the settlement of previously disclosed securities litigation in the United States District Court for the Middle District of Tennessee. In that filing, Acadia outlined the monetary terms of the settlement, the absence of any admission or finding of liability, and its intention to fund the settlement through anticipated insurance proceeds, cash on hand and existing credit lines. Filings also discuss professional and general liability reserves and their impact on the company’s financial outlook.
On Stock Titan, Acadia’s SEC filings are updated as they are made available through EDGAR. AI-powered summaries highlight key points from lengthy documents, helping users quickly understand items such as earnings releases, guidance revisions, executive compensation arrangements, transition and employment agreements, and other governance-related disclosures. Users can also review insider and executive-related information contained in relevant filings to better understand management changes and contractual terms.
Acadia Healthcare Company, Inc. executive Brian Farley, EVP, CLAO and Secretary, reported an equity award of common stock. He acquired 37,510 shares of common stock at $0.00 per share as a grant classified as a “grant, award, or other acquisition.”
These shares will vest over three years in equal yearly installments beginning on April 10, 2027, so the award is subject to a multi‑year service-based schedule. Following this grant, Farley directly holds 144,185 shares of Acadia Healthcare common stock. This is a compensation-related grant rather than an open-market trade.
Acadia Healthcare reported first-quarter 2026 revenue of $828.8 million, up 7.6% from $770.5 million a year earlier, driven by higher same-facility volumes and pricing. Medicaid represented 60.7% of revenue, reflecting the company’s focus on publicly funded behavioral health services.
Net income attributable to Acadia fell to $4.1 million, or $0.05 per diluted share, compared with $8.4 million and $0.09 a year earlier, as higher interest expense and legal-related costs weighed on results. Legal settlements expense rose to $13.8 million, mainly from an agreement in principle to resolve the Sandoval wrongful death litigation.
Operating cash flow strengthened to $61.5 million from $11.5 million, helped by working-capital improvements, while cash ended the quarter at $158.5 million. Total debt stood at about $2.53 billion, including term loans and three series of senior notes. The company operates 275 facilities with roughly 12,400 beds and continues to invest in growth through new beds, joint ventures and de novo facilities.
Acadia Healthcare Company, Inc. reported first quarter 2026 revenue of $828.8 million, up 7.6% from $770.5 million a year earlier, driven by 7.3% same-facility revenue growth and higher patient volumes and pricing. Acute inpatient revenue rose 14%, while residential and comprehensive treatment facilities posted modest gains and specialty treatment facilities declined.
Adjusted EBITDA increased to $144.2 million from $134.2 million, but reported diluted EPS fell to $0.05 from $0.09 and adjusted EPS declined to $0.37 from $0.40 as interest expense and legal settlement costs rose. The company added 82 new beds in the quarter, ended with $158.5 million in cash, and reported a 3.9x net leverage ratio. Management raised full-year 2026 guidance, targeting revenue of $3.37–$3.45 billion, adjusted EBITDA of $580–$615 million, and adjusted EPS of $1.35–$1.60.
Acadia Healthcare Co Inc reports a Schedule 13G showing Vanguard Capital Management beneficially owns 4,838,637 shares of Common Stock, representing 5.25% of the class. The filing states Vanguard has sole dispositive power over 4,838,637 shares and sole voting power over 683,836 shares. The filing is signed by Ashley Grim on 04/29/2026.
Acadia Healthcare Co Inc reports a Schedule 13G disclosure showing Vanguard Portfolio Management beneficially owns 5,079,563 shares of Common Stock, equal to 5.51% of the class. The filing states Vanguard Portfolio Management has sole dispositive power over 5,079,563 shares and sole voting power over 18,125 shares. The disclosure is signed by Ashley Grim on 04/28/2026 and cites the portfolio management and affiliated Vanguard entities described in the release.
Acadia Healthcare Company, Inc. reported a planned Chief Financial Officer transition and reaffirmed its first quarter and full-year 2026 financial guidance. Todd Young will resign as CFO effective April 30, 2026 and will participate in the April 30 earnings call.
The Board appointed former CFO David M. Duckworth as Interim CFO and principal financial officer effective May 1, 2026. His employment agreement runs initially through May 1, 2027, with a base salary of $100,000 per month and eligibility for a $125,000 quarterly cash bonus, plus defined severance protections.
The company highlighted Duckworth’s long prior tenure as CFO from 2012 to 2023 and reiterated that its previously issued 2026 outlook remains in place. Acadia also described customary confidentiality, non-competition and indemnification arrangements associated with his role.
YOUNG TODD S. reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. Chief Financial Officer Todd S. Young reported a compensation-related equity grant of 58,799 shares of common stock on April 10, 2026. The shares were granted at no cash cost to him and are scheduled to vest over three years in equal yearly installments beginning on April 10, 2027. After this award, he directly holds a total of 107,244 common shares, showing this is a sizable but routine stock-based compensation grant rather than an open-market purchase.
Farley Brian reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. reported that EVP, General Counsel and Secretary Brian Farley received a grant of 37,510 shares of common stock on April 10, 2026. The award was granted at no cash cost per share and is part of his equity compensation.
The shares will vest over a three-year period in equal yearly installments beginning on April 10, 2027, tying the benefit to continued service. After this award, Farley directly holds a total of 106,675 shares of Acadia Healthcare common stock.
Acadia Healthcare Co Inc: The Vanguard Group filed an amended Schedule 13G/A reporting that, following an internal realignment, certain Vanguard subsidiaries will report holdings separately under SEC Release No. 34-39538. The amendment states 0 shares beneficially owned of Acadia Healthcare common stock as reported in the filing dated 03/13/2026.
The filing explains the realignment occurred on January 12, 2026 and that Vanguard no longer is deemed to beneficially own securities held by those subsidiaries; it is signed by Ashley Grim on 03/26/2026.